Evogene Ltd.
Pioneering Real-World Innovation in Computational Chemistry for Pharma & Agriculture

Evogene Ltd. (Nasdaq, TASE: EVGN) is a pioneering computational chemistry company developing generative AI to design and optimize small molecules for the pharmaceutical and agricultural industries.

Latest Press Releases

Presentations
Download PDF
28.04.2026

Latest Financial Results

Q1 2026 EARNINGS CALLS

Earnings Call Presentation

View Previous calls Close Previous calls

Financial Results

20.05.2026
Press Release
  • EVGN Q3 2024 Results
  • EVGN Q2 2024 Results
  • EVGN Q1 2024 Results
  • EVGN Q4 2023 Results Transcript
  • EVGN Q3 2023 Results Transcript
  • EVGN Q2 2023 Results Transcript
  • EVGN Q1 2023 Results Transcript
  • EVGN Q4 2022 Results Script Transcript
  • EVGN Q3 2022 Results Transcript
  • EVGN Q2 2022 Results Transcript
  • EVGN Q1 2022 Results Transcript
  • EVGN Q4 2021 Results Transcript
  • EVGN Q3 2021 Results Transcript
  • EVGN Q2 2021 Results Script FINAL
  • EVGN Q1 2021 Results Script FINAL
  • Evogene Full Year and Fourth Quarter 2020 Results Script Final 030321
  • EVGN Q3 2020 Results Script FINAL
  • EVGN Q2 2020 Results Transcript
  • EVGN Q1 2020 Results Script FINAL_Recorded
  • EVGN Q4 2019 Results Script Transcript
  • EVGN Q3 2019 Results Script FINAL
  • EVGN Q2 2019 Results Script Transcript
  • EVGN Q1 2019 Results Transcript

    • Sign Up for Investor Relations Email Alerts




      Investor Relations Contact

      Ofer Haviv
      President and CEO

      IR@evogene.com

      +972-8-9311900